JP2013527772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527772A5 JP2013527772A5 JP2013510163A JP2013510163A JP2013527772A5 JP 2013527772 A5 JP2013527772 A5 JP 2013527772A5 JP 2013510163 A JP2013510163 A JP 2013510163A JP 2013510163 A JP2013510163 A JP 2013510163A JP 2013527772 A5 JP2013527772 A5 JP 2013527772A5
- Authority
- JP
- Japan
- Prior art keywords
- pla2
- subject
- level
- cvd
- determined
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000016752 1-Alkyl-2-acetylglycerophosphocholine Esterase Human genes 0.000 claims 10
- 108010024976 Asparaginase Proteins 0.000 claims 10
- 238000000034 method Methods 0.000 claims 8
- 208000032109 Transient ischaemic attack Diseases 0.000 claims 2
- 206010053648 Vascular occlusion Diseases 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 208000026106 cerebrovascular disease Diseases 0.000 claims 2
- 208000029078 coronary artery disease Diseases 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 230000002537 thrombolytic effect Effects 0.000 claims 2
- 201000010875 transient cerebral ischemia Diseases 0.000 claims 2
- 231100000216 vascular lesion Toxicity 0.000 claims 2
- 208000021331 vascular occlusion disease Diseases 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010010356 Congenital anomaly Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 230000007555 cardiovascular defect Effects 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 208000019553 vascular disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33019310P | 2010-04-30 | 2010-04-30 | |
| US61/330,193 | 2010-04-30 | ||
| PCT/US2011/034728 WO2011137419A1 (en) | 2010-04-30 | 2011-05-02 | Methods using lipoprotein-associated phospholipase a2 in an acute care setting |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013527772A JP2013527772A (ja) | 2013-07-04 |
| JP2013527772A5 true JP2013527772A5 (enExample) | 2014-08-14 |
Family
ID=44861949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510163A Pending JP2013527772A (ja) | 2010-04-30 | 2011-05-02 | 急性期ケア環境においてリポタンパク質関連ホスホリパーゼａ２を使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20130236450A1 (enExample) |
| EP (1) | EP2563914A4 (enExample) |
| JP (1) | JP2013527772A (enExample) |
| CN (1) | CN103124785A (enExample) |
| CA (1) | CA2798122A1 (enExample) |
| WO (1) | WO2011137419A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166777A1 (en) | 2004-04-16 | 2007-07-19 | Yaping Shou | Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity |
| US20150017671A1 (en) | 2004-04-16 | 2015-01-15 | Yaping Shou | Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity |
| US20140283157A1 (en) | 2013-03-15 | 2014-09-18 | Diadexus, Inc. | Lipoprotein-associated phospholipase a2 antibody compositions and methods of use |
| WO2015123598A1 (en) * | 2014-02-14 | 2015-08-20 | Diadexus, Inc. | Biomarkers for cardiovascular disease |
| KR101629560B1 (ko) * | 2014-07-30 | 2016-06-13 | 경희대학교 산학협력단 | 부작용이 억제된 암치료용 약학 조성물 |
| WO2017221795A1 (ja) | 2016-06-22 | 2017-12-28 | 旭化成ファーマ株式会社 | Ｌｐ－ＰＬＡ２活性の測定 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6161547A (en) * | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
| WO2004089184A2 (en) * | 2003-04-01 | 2004-10-21 | Diadexus, Inc. | NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK |
| AU2003902115A0 (en) * | 2003-05-02 | 2003-05-22 | The University Of Queensland | Method of predicting functional outcome of a stroke using eeg measures |
| WO2005116268A2 (en) * | 2004-05-27 | 2005-12-08 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health | Differential expression of molecules associated with acute stroke |
| EP2166358A1 (en) * | 2008-09-17 | 2010-03-24 | Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron | Differential diagnostic biomarkers of stroke mimicking conditions and methods of use thereof |
-
2011
- 2011-05-02 JP JP2013510163A patent/JP2013527772A/ja active Pending
- 2011-05-02 EP EP11775687.4A patent/EP2563914A4/en not_active Withdrawn
- 2011-05-02 CA CA2798122A patent/CA2798122A1/en not_active Abandoned
- 2011-05-02 CN CN2011800326354A patent/CN103124785A/zh active Pending
- 2011-05-02 US US13/695,027 patent/US20130236450A1/en not_active Abandoned
- 2011-05-02 WO PCT/US2011/034728 patent/WO2011137419A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nagamoto et al. | Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran | |
| JP2013527772A5 (enExample) | ||
| Rallidis et al. | Right ventricular involvement in coronary artery disease: role of echocardiography for diagnosis and prognosis | |
| JP2011162558A5 (enExample) | ||
| Chao et al. | Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation | |
| Emter et al. | Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine | |
| Gallagher et al. | Lifestyle management to prevent and treat atrial fibrillation | |
| CA2798122A1 (en) | Methods using lipoprotein-associated phospholipase a2 in an acute care setting | |
| Nar et al. | Evaluation of the relationship between arterial blood pressure, aortic stiffness and serum endothelin-1 levels in patients with essential hypertension | |
| Masugata et al. | Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension | |
| Trueblood et al. | Biphasic temporal pattern in exercise capacity after myocardial infarction in the rat: relationship to left ventricular remodeling | |
| Ishida et al. | Attenuation of bone morphogenetic protein receptor type 2 expression in the pulmonary arteries of patients with failed Fontan circulation | |
| Mercier et al. | A reliable piglet model of chronic thrombo-embolic pulmonary hypertension | |
| Komar et al. | Elevated level of plasma endothelin-1 in patients with atrial septal defect | |
| Kang et al. | A case of a senile systemic amyloidosis patient presenting with angina pectoris and dilated cardiomyopathy | |
| Anderson et al. | Pulmonary Arteriovenous Malformations Presenting as Platypnea‐Orthodeoxia in Graft‐Versus‐Host Disease | |
| Fendrikova et al. | Gender differences in antihypertensive efficiency of combination pharmacotherapy in patients with resistant hypertension and abdominal obesity in relation to salt sensitivity | |
| Oduncu | Response to Immediate and Long‐Term Results Following Balloon Mitral Valvotomy in Patients With Atrial Fibrillation | |
| Следзевська et al. | Value of the exercise test in patients with postinfarction cardiosclerosis for evaluation of prognosis and efficiency of the rehabilitation treatment | |
| Conger et al. | Clinical And Hemodynamic Characterization Of Intermediate-And Long-Term Responders To Iv Prostacyclin | |
| Gao | ASSA13-16-2 Relationship Between Cholesteryl Ester Transfer Protein Gene–629C Æ A Mutations with HDL-C Levels and Coronary Heart Disease | |
| Suman et al. | Etiology of chronic heart failure in indian subjects | |
| Chalikias et al. | Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation | |
| Yong et al. | ASSA13-16-3 Dyslipidemia in Chinese Elderly Patients with Acute Myocardial Infarction | |
| Hai et al. | ASSA13-16-4 The Influence of Combination of Amlodipine and Valsartan on Plasma Free Fat Acid and Adiponectin in Patients with Essential Hypertension |